Author:
Jadoul Michel,Berenguer Marina C.,Doss Wahid,Fabrizi Fabrizio,Izopet Jacques,Jha Vivekanand,Kamar Nassim,Kasiske Bertram L.,Lai Ching-Lung,Morales José M.,Patel Priti R.,Pol Stanislas,Silva Marcelo O.,Balk Ethan M.,Gordon Craig E.,Earley Amy,Di Mengyang,Martin Paul
Reference7 articles.
1. KDIGO 2018 clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease;Kidney Int Suppl,2018
2. Transmission of hepatitis C virus in dialysis units: a systematic review of reports on outbreaks;Fabrizi;Int J Artif Organs,2015
3. Reau N, Kwo PY, Rhee S, et al. Glecaprevir/pibrentasvir treatment in liver or kidney transplant patients with hepatitis C virus infection [e-pub ahead of print]. Hepatology. https://doi.org/10.1002/hep.30046. Accessed July 25, 2018.
4. Access to hepatitis C virus treatment: lessons from implementation of strategies for increasing access to antiretroviral treatment;Assefa;Int J Infect Dis,2018
5. Progress Report on Access to Hepatitis C Treatment. Focus on Overcoming Barriers in Low- and Middle-Income Countries,2018
Cited by
71 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献